Global Pharmaceuticals & Biotech ROE over 20

Johnson & Johnson

Market Cap: US$644.3b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Vertex Pharmaceuticals

Market Cap: US$136.9b

Operates as a biotechnology company in the United States, Europe, and internationally.

Bristol-Myers Squibb

Market Cap: US$133.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

IQVIA Holdings

Market Cap: US$42.1b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Illumina

Market Cap: US$32.2b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Incyte

Market Cap: US$25.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

United Therapeutics

Market Cap: US$22.3b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Exelixis

Market Cap: US$13.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Ligand Pharmaceuticals

Market Cap: US$5.7b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Sotera Health

Market Cap: US$5.5b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Organon

Market Cap: US$3.6b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Eton Pharmaceuticals

Market Cap: US$1.7b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

Phibro Animal Health

Market Cap: US$1.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

MeiraGTx Holdings

Market Cap: US$1.4b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

Zevra Therapeutics

Market Cap: US$706.1m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

CorMedix

Market Cap: US$641.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Q32 Bio

Market Cap: US$472.1m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

Anbio Biotechnology

Market Cap: US$321.7m

Provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally.

Compugen

Market Cap: US$251.0m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

Protalix BioTherapeutics

Market Cap: US$191.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Vaxart

Market Cap: US$126.2m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.

Rallybio

Market Cap: US$88.2m

A clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

Actinium Pharmaceuticals

Market Cap: US$35.2m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Bio Green Med Solution

Market Cap: US$5.8m

Engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.